Nuix Limited
ASX:NXL.AX
7.6 (AUD) • At close November 8, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) AUD.
| 2024 Q4 | 2024 Q2 | 2023 Q4 | 2023 Q2 | 2022 Q4 | 2022 Q2 | 2021 Q4 | 2021 Q2 | 2020 Q4 | 2020 Q2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 122.176 | 98.441 | 94.829 | 87.636 | 68.29 | 84.02 | 90.742 | 85.326 | 87.075 | 88.784 |
| Cost of Revenue
| 11.552 | 33.214 | 31.735 | 31.605 | 28.306 | 25.718 | 25.95 | 23.973 | 26.355 | 22.731 |
| Gross Profit
| 110.624 | 65.227 | 63.094 | 56.031 | 39.984 | 58.302 | 64.792 | 61.353 | 60.72 | 66.053 |
| Gross Profit Ratio
| 0.905 | 0.663 | 0.665 | 0.639 | 0.586 | 0.694 | 0.714 | 0.719 | 0.697 | 0.744 |
| Reseach & Development Expenses
| 35.229 | 8.574 | 13.237 | 8.457 | 8.774 | 7.089 | 5.318 | 5.457 | 5.817 | 2.362 |
| General & Administrative Expenses
| 22.803 | 20.139 | 23.77 | 18.426 | 30.818 | 19.656 | 14.564 | 48.142 | 11.839 | 12.464 |
| Selling & Marketing Expenses
| 39.7 | 33.839 | 36.662 | 28.377 | 30.309 | 29.713 | 26.56 | 25.839 | 31.806 | 32.269 |
| SG&A
| 63.549 | 63.299 | 57.185 | 47.365 | 51.992 | 55.181 | 41.523 | 39.631 | 41.749 | 43.325 |
| Other Expenses
| -1.468 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Expenses
| 97.31 | 71.873 | 70.422 | 55.822 | 60.766 | 62.27 | 46.841 | 45.088 | 47.566 | 45.687 |
| Operating Income
| 13.314 | -6.646 | -7.328 | 0.209 | -20.782 | -3.968 | 17.951 | 16.265 | 13.154 | 20.366 |
| Operating Income Ratio
| 0.109 | -0.068 | -0.077 | 0.002 | -0.304 | -0.047 | 0.198 | 0.191 | 0.151 | 0.229 |
| Total Other Income Expenses Net
| -0.018 | 0.962 | 1.206 | -0.441 | -0.621 | 0.109 | 1.128 | -39.304 | -0.566 | -0.532 |
| Income Before Tax
| 13.296 | -5.684 | -6.122 | -0.232 | -21.403 | -3.859 | 19.079 | -23.039 | 12.588 | 19.834 |
| Income Before Tax Ratio
| 0.109 | -0.058 | -0.065 | -0.003 | -0.313 | -0.046 | 0.21 | -0.27 | 0.145 | 0.223 |
| Income Tax Expense
| 3.44 | -0.854 | 0.718 | -1.483 | -0.936 | -1.535 | 3.92 | -6.474 | 3.48 | 5.355 |
| Net Income
| 9.856 | -4.83 | -6.84 | 1.251 | -20.467 | -2.324 | 15.159 | -16.565 | 9.109 | 14.479 |
| Net Income Ratio
| 0.081 | -0.049 | -0.072 | 0.014 | -0.3 | -0.028 | 0.167 | -0.194 | 0.105 | 0.163 |
| EPS
| 0.03 | -0.015 | -0.022 | 0.004 | -0.065 | -0.007 | 0.048 | -0.052 | 0.029 | 0.046 |
| EPS Diluted
| 0.03 | -0.015 | -0.022 | 0.004 | -0.065 | -0.007 | 0.048 | -0.052 | 0.029 | 0.046 |
| EBITDA
| 33.093 | 16.625 | 13.306 | 20.266 | -2.389 | 13.223 | 34.252 | 31.036 | 28.268 | 33.652 |
| EBITDA Ratio
| 0.271 | 0.169 | 0.14 | 0.231 | -0.035 | 0.157 | 0.377 | 0.364 | 0.325 | 0.379 |